Dr. Douglas J. Alexander II, MD
Psychiatry (Addiction Psychiatry Physician)
- Medicare participating
At a glance
- Medical school
- Louisiana State University School of Medicine in New Orleans (2018)
- Years since graduation
- 8
- In the NPI registry since
- 2018
- Medicare patients seen, 2024
- 47
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2018Medical school: Louisiana State University School of Medicine in New Orleans
- 2018Registered with an NPI (national billing number; not a license date)
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Addiction Psychiatry Physician primary
LA license 320999
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- University Medical Center New Orleans New Orleans, LA
Medical groups
- University of Rochester (973 clinicians)
- Administrators of the Tulane Educational Fund (393 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 47
- Services billed
- 85
- Patients’ average age
- 50
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Payments from drug and device companies
In 2025, 7 companies reported 8 payments worth $219 in total to this clinician.
| Supernus Pharmaceuticals, Inc. | $77.57 |
|---|---|
| Teva Pharmaceuticals USA, Inc. | $34.74 |
| Otsuka America Pharmaceutical, Inc. | $29.08 |
| Alkermes, Inc. | $23.31 |
| Vanda Pharmaceuticals Inc. | $18.74 |
| E.r. Squibb & Sons, L.l.c. | $18.47 |
| Janssen Pharmaceuticals, Inc | $16.86 |
| Food and Beverage | $219 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.